Eiry Roberts reports a stock award at Neurocrine Biosciences
By AlphaYouPublished Form 4
ROBERTS EIRY
Reporting filer
Eiry Roberts reports a stock award, not an open-market purchase or sale, in Neurocrine Biosciences Inc. Form 4 filed Nov 5, 2026 lists 2 entries.
- Disclosed
- Nov 5, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (derivative) | ROBERTS EIRY | 2026-11-04 | A | Grant or award | 8314 | 0 | 8,314 | 1 day | Filed terms
|
| Restricted Stock Unit (derivative) | ROBERTS EIRY | 2026-11-04 | A | Grant or award | 1506 | 0 | 1,506 | 1 day | Filed terms
|
Stock Option (derivative)
- Owner
- ROBERTS EIRY
- Date
- 2026-11-04
- Code
- A
- Action
- Grant or award
- Quantity
- 8314
- Price
- 0
- Following holdings
- 8,314
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option
- conversion Or Exercise Price: 166.05
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 8314
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-04
- underlying Security Title: Common Stock
- underlying Security Shares: 8314
- shares Owned Following Transaction: 8314
- direct Or Indirect Ownership: D
Restricted Stock Unit (derivative)
- Owner
- ROBERTS EIRY
- Date
- 2026-11-04
- Code
- A
- Action
- Grant or award
- Quantity
- 1506
- Price
- 0
- Following holdings
- 1,506
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Restricted Stock Unit
- id: F2
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 1506
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- id: F3
- underlying Security Title: Common Stock
- underlying Security Shares: 1506
- shares Owned Following Transaction: 1506
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- ROBERTS EIRY: Chief Medical Officer.
- F1: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on December 4, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
- F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F3: The Restricted Stock Units will settle annually at 1/4 of the units settling on each of November 4, 2027, November 4, 2028, November 4, 2029, and November 4, 2030.
Original sources
Prepared automatically from public filing data. Report a correction.